- Hospitaler/Afdelinger Se de enkelte afdelingers forskningsprofil
- Forskere Søg forskere og deres videnskabelige arbejde
- Publikationer Publikationer med forskere fra Region Hovedstaden
- Forskningsprojekter Søg projekter/clinical trials i Region Hovedstaden
- Aktiviteter Med forskere fra Region Hovedstaden
Forskning
Udskriv
Switch language
Region Hovedstaden
- en del af Københavns Universitetshospital
Udgivet
Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group
Publikation: Bidrag til tidsskrift › Review › peer review
Harvard
Morillon, MB, Christensen, R, Singh, JA, Dalbeth, N, Saag, K, Taylor, WJ, Neogi, T, Kennedy, MA, Pedersen, BM, McCarthy, GM, Shea, B, Diaz-Torne, C, Tedeschi, SK, Grainger, R, Abhishek, A, Gaffo, A, Nielsen, SM, Noerup, A, Simon, LS, Lassere, M, Tugwell, P, Stamp, LK & Gout Working Group, FTO 2021, 'Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group', Seminars in Arthritis and Rheumatism, bind 51, nr. 6, s. 1378-1385. https://doi.org/10.1016/j.semarthrit.2021.11.004
APA
Morillon, M. B., Christensen, R., Singh, J. A., Dalbeth, N., Saag, K., Taylor, W. J., Neogi, T., Kennedy, M. A., Pedersen, B. M., McCarthy, G. M., Shea, B., Diaz-Torne, C., Tedeschi, S. K., Grainger, R., Abhishek, A., Gaffo, A., Nielsen, S. M., Noerup, A., Simon, L. S., ... Gout Working Group, F. T. O. (2021). Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group. Seminars in Arthritis and Rheumatism, 51(6), 1378-1385. https://doi.org/10.1016/j.semarthrit.2021.11.004
CBE
Morillon MB, Christensen R, Singh JA, Dalbeth N, Saag K, Taylor WJ, Neogi T, Kennedy MA, Pedersen BM, McCarthy GM, Shea B, Diaz-Torne C, Tedeschi SK, Grainger R, Abhishek A, Gaffo A, Nielsen SM, Noerup A, Simon LS, Lassere M, Tugwell P, Stamp LK, Gout Working Group FTO. 2021. Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group. Seminars in Arthritis and Rheumatism. 51(6):1378-1385. https://doi.org/10.1016/j.semarthrit.2021.11.004
MLA
Morillon, Melanie Birger o.a.. "Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group". Seminars in Arthritis and Rheumatism. 2021, 51(6). 1378-1385. https://doi.org/10.1016/j.semarthrit.2021.11.004
Vancouver
Morillon MB, Christensen R, Singh JA, Dalbeth N, Saag K, Taylor WJ o.a. Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group. Seminars in Arthritis and Rheumatism. 2021 dec.;51(6):1378-1385. https://doi.org/10.1016/j.semarthrit.2021.11.004
Author
Bibtex
@article{162d6365f8974660ba8f334c9be31e87,
title = "Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group",
abstract = "Serum urate (SU) is the most common primary efficacy outcome in trials of urate-lowering therapies for gout. Despite this, it is not formally considered a validated surrogate outcome. In this paper we will outline the definitions of biomarkers and surrogate outcome measures, respectively as well as the available frameworks and challenges in the assessment of the validity of serum urate as a surrogate in gout (i.e. a reasonable replacement for gout symptoms).",
author = "Morillon, {Melanie Birger} and Robin Christensen and Singh, {Jasvinder A} and Nicola Dalbeth and Kenneth Saag and Taylor, {William J} and Tuhina Neogi and Kennedy, {Martin A} and Pedersen, {Birthe M} and McCarthy, {Geraldine M} and Beverley Shea and Cesar Diaz-Torne and Tedeschi, {Sara K} and Rebecca Grainger and Abhishek Abhishek and Angelo Gaffo and Nielsen, {Sabrina Mai} and Alexander Noerup and Simon, {Lee S} and Marissa Lassere and Peter Tugwell and Stamp, {Lisa K} and {Gout Working Group}, {For The Omeract}",
note = "Copyright {\textcopyright} 2021 Elsevier Inc. All rights reserved.",
year = "2021",
month = dec,
doi = "10.1016/j.semarthrit.2021.11.004",
language = "English",
volume = "51",
pages = "1378--1385",
journal = "Seminars in Arthritis and Rheumatism",
issn = "0049-0172",
publisher = "W.B./Saunders Co",
number = "6",
}
RIS
TY - JOUR
T1 - Serum urate as a proposed surrogate outcome measure in gout trials
T2 - From the OMERACT working group
AU - Morillon, Melanie Birger
AU - Christensen, Robin
AU - Singh, Jasvinder A
AU - Dalbeth, Nicola
AU - Saag, Kenneth
AU - Taylor, William J
AU - Neogi, Tuhina
AU - Kennedy, Martin A
AU - Pedersen, Birthe M
AU - McCarthy, Geraldine M
AU - Shea, Beverley
AU - Diaz-Torne, Cesar
AU - Tedeschi, Sara K
AU - Grainger, Rebecca
AU - Abhishek, Abhishek
AU - Gaffo, Angelo
AU - Nielsen, Sabrina Mai
AU - Noerup, Alexander
AU - Simon, Lee S
AU - Lassere, Marissa
AU - Tugwell, Peter
AU - Stamp, Lisa K
AU - Gout Working Group, For The Omeract
N1 - Copyright © 2021 Elsevier Inc. All rights reserved.
PY - 2021/12
Y1 - 2021/12
N2 - Serum urate (SU) is the most common primary efficacy outcome in trials of urate-lowering therapies for gout. Despite this, it is not formally considered a validated surrogate outcome. In this paper we will outline the definitions of biomarkers and surrogate outcome measures, respectively as well as the available frameworks and challenges in the assessment of the validity of serum urate as a surrogate in gout (i.e. a reasonable replacement for gout symptoms).
AB - Serum urate (SU) is the most common primary efficacy outcome in trials of urate-lowering therapies for gout. Despite this, it is not formally considered a validated surrogate outcome. In this paper we will outline the definitions of biomarkers and surrogate outcome measures, respectively as well as the available frameworks and challenges in the assessment of the validity of serum urate as a surrogate in gout (i.e. a reasonable replacement for gout symptoms).
UR - http://www.scopus.com/inward/record.url?scp=85120337109&partnerID=8YFLogxK
U2 - 10.1016/j.semarthrit.2021.11.004
DO - 10.1016/j.semarthrit.2021.11.004
M3 - Review
C2 - 34839932
VL - 51
SP - 1378
EP - 1385
JO - Seminars in Arthritis and Rheumatism
JF - Seminars in Arthritis and Rheumatism
SN - 0049-0172
IS - 6
ER -
ID: 70330157